These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4663747)

  • 1. [A new multienzyme complex. Clinical trial in hepatitis and cirrhosis].
    Ribet A; Vidal JL
    Nouv Presse Med; 1972 Nov; 1(42):2843-4. PubMed ID: 4663747
    [No Abstract]   [Full Text] [Related]  

  • 2. [Enzymatic therapy in hepatology with ornithine carbamol transferase].
    Monges H; Hancy A; Codinach N
    Mars Med; 1971; 108(12):881-5. PubMed ID: 5145506
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of hepatocellular insufficiency with ornithine carbamyl transferase].
    Heully F; Gaucher P; Jeanpierre R
    Therapeutique; 1972; 48(5):381-4. PubMed ID: 5076530
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic use of ornithine-carbamyl-transferase in liver diseases].
    Maccá F; Gatta A; Caregaro L; Lauro S; Milani L; Zuin R; Menozzi L
    Minerva Dietol Gastroenterol; 1982; 28(1):71-8. PubMed ID: 7078779
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of ornithine carbamoyltransferase in the treatment of liver diseases].
    Caruso N; De Jacobis M; Roccato M; Sequino A; Sgoifo B; Tinello M
    Clin Ter; 1984 Jul; 110(1):37-44. PubMed ID: 6237844
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinico-biological therapeutic effect of intramuscular ornithine-carbamyl-transferase in chronic active hepatitis].
    Sanchís Closa A; Caballería Rovira E; Arago López JV; Massó Ubeda RM
    Rev Esp Enferm Apar Dig; 1988 Apr; 73(4):351-4. PubMed ID: 3387645
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical trial of alpha ornithine ketoglutarate].
    Linquette M; Fossati P; Hubschman B
    Lille Med; 1969 Apr; 14():Suppl 3:512-5. PubMed ID: 5376446
    [No Abstract]   [Full Text] [Related]  

  • 8. [New study of O.C.T. in minor hepatic disorders and sequelae of hepatitis].
    Walter H; Nepveux O
    Sem Hop; 1966 Dec; 42():Suppl:53-6. PubMed ID: 4296260
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prednisolone therapy of patients with chronic hepatitis and cirrhosis of the liver].
    Vasil'eva LN
    Klin Med (Mosk); 1966 May; 44(5):42-8. PubMed ID: 5990929
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical study on the treatment of liver disease with glucocorticoids].
    Oda T; Suzuki H; Naito C; Yamanada M; Oka H
    Saishin Igaku; 1969 Oct; 24(10):2119-29. PubMed ID: 5349229
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ornithine carbamoyltransferase activity of mitochondrial suspensions of normal and pathological human liver obtained by needle biopsy].
    Giglio F; Migneco G; Le Moli S; Pagliaro L
    Boll Soc Ital Biol Sper; 1964 Nov; 40(22):1403-7. PubMed ID: 5877191
    [No Abstract]   [Full Text] [Related]  

  • 12. [Recent findings in drug treatment of liver disease patients with ornithine-carbamyl-transferase (OCT). Personal experience].
    Alvisi V; Tralli M; Tampieri ML; Lo Ponte A; D'Ambrosi A
    Minerva Dietol Gastroenterol; 1982; 28(4):335-40. PubMed ID: 7167246
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunoprevention and immunosuppression of chronic inflammatory liver diseases].
    Scheiffarth F
    Med Welt; 1974 Oct; 25(40):1589-92. PubMed ID: 4444495
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical study on the effects of L-ornithine-L-aspartate on liver dysfunction].
    Kosozu K
    Iryo; 1966 Apr; 20(4):339-46. PubMed ID: 5974192
    [No Abstract]   [Full Text] [Related]  

  • 15. [Uridine-5-diphosphoglucose in the therapy of hepatopathies of diverse etiology].
    De las Casas Alonso P; Carballo García L; Silverio García C
    Rev Esp Enferm Apar Dig; 1974 Mar; 42(5):561-74. PubMed ID: 4825335
    [No Abstract]   [Full Text] [Related]  

  • 16. [Glucocorticotherapy in hepatic diseases].
    Boroń P; Borzuchowska A; Modzelewski T
    Przegl Lek; 1970; 26(10):753-5. PubMed ID: 5484242
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical study of citiolone, cyto-membranous hepatic protector].
    Varay A; Castel A; Bloch J
    Therapeutique; 1970 Dec; 46(10):993-5. PubMed ID: 5511936
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the therapy of chronic inflammatory liver diseases without or with vitamin B 12-folic acid].
    Burgmann W
    Munch Med Wochenschr; 1966 Sep; 108(37):1805-8. PubMed ID: 6014771
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical and biological effectiveness of citiolone and importance of its contribution in hepatic therapeutics].
    Duché G
    Therapeutique; 1970 Dec; 46(10):1037-41. PubMed ID: 5511931
    [No Abstract]   [Full Text] [Related]  

  • 20. [Reflections on prednisone therapy of patients with liver diseases].
    Teichmann W
    Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):25-7. PubMed ID: 5501421
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.